DGAP-News: Carl Zeiss Meditec achieves further significant growth in revenue and order intake after nine months of 2021/22

Carl Zeiss Meditec generated revenue of 1,332.9m in the first nine months of fiscal year 2021/22 (prior year: 1,198.2m), corresponding to an increase of 11.2% (adjusted for currency effects: +9.8%) compared with the same period of the prior year.